세계의 환자 모니터링 기기 시장 예측(-2030년) : 제품별, 최종사용자별, 지역별 분석

According to Stratistics MRC, the Global Patient Monitoring Devices Market is accounted for $46.9 billion in 2023 and is expected to reach $98.1 billion by 2030 growing at a CAGR of 11.1% during the forecast period. The patient monitoring devices industry is involved in the development, manufacturing, and distribution of devices used to monitor and track patients' vital signs, physiological parameters, and overall health status. These devices encompass a wide range of tools, from bedside monitors in hospitals to portable or wearable devices for continuous monitoring outside clinical settings. They often measure parameters like heart rate, blood pressure, temperature, oxygen saturation, and more, enabling healthcare professionals to assess patient health in real-time, facilitate early intervention, and monitor conditions for better diagnosis and treatment.

According to World Health Organization (WHO), chronic diseases account for around 73% of all deaths and 60% of the global burden of disease in 2020. Moreover, developing economies account for 79% of deaths attributed to these diseases.

Market Dynamics:

Driver:

Increasing inclination toward wearable patient monitoring devices

The growing preference for wearable patient monitoring devices serves as a key driver in the patient monitoring devices market. These devices offer real-time health data, enabling continuous and remote monitoring of vital signs and health parameters. Their non-intrusive nature and convenience empower patients to actively participate in their healthcare, promoting early detection of abnormalities and chronic conditions. With advancements in technology, including miniaturization and enhanced connectivity, wearable monitoring devices provide healthcare professionals with comprehensive insights, improving diagnosis and preventive care, thus driving market growth.

Restraint:

Accuracy and reliability of certain monitoring devices

While technological advancements have improved monitoring capabilities, concerns persist regarding the precision and reliability of some devices. Variations in readings, calibration issues, and inaccuracies in data interpretation can impact clinical decisions and patient care. Additionally, the complexity of certain devices may contribute to operator error or inadequate training, further compromising accuracy. Consequently, this inhibits broader adoption and integration of these devices into routine clinical practices, hindering the market expansion.

Opportunity:

Increasing prevalence of chronic diseases

Chronic conditions like cardiovascular diseases, diabetes, and respiratory disorders demand continuous monitoring, fostering the need for advanced patient monitoring devices. These devices facilitate remote health monitoring, real-time data collection, and timely interventions, enhancing patient care and management. As the population affected by chronic illnesses rises, the demand for innovative, non-invasive monitoring solutions is growing, which is aiding in market expansion for patient monitoring devices.

Threat:

Lack of standardization and compatibility

Due to its potential to hinder seamless integration, data sharing, and interoperability among devices and systems, a lack of standardization and compatibility poses a significant threat to the market. Variations in data formats, communication protocols, and device interfaces can impede the exchange of information between different monitoring devices and healthcare IT systems. This lack of uniformity often leads to interoperability challenges, making it difficult for healthcare providers to aggregate, analyze, and utilize patient data efficiently. Moreover, the absence of standardized protocols may limit the ability to incorporate new technologies and devices into existing healthcare ecosystems, leading to fragmentation and inefficiencies. All of these factors hinder market growth.

COVID-19 Impact:

The COVID-19 pandemic significantly impacted the patient monitoring device market by accelerating the demand for remote monitoring solutions. With hospitals overwhelmed and the need to reduce in-person visits, remote patient monitoring devices experienced a surge in adoption. Additionally, there was a heightened focus on advanced monitoring systems to track vital signs and oxygen levels in COVID-19 patients, further spurring the development and deployment of such devices during this period.

The hospitals segment is expected to be the largest during the forecast period

Over the forecast period, the hospitals segment is expected to be the largest. The dominance of hospitals is attributed to their extensive and varied use of monitoring equipment across departments. Hospitals serve as primary centers for acute care, critical care, surgeries, and specialized treatments. With a high volume of patients requiring continuous monitoring, hospitals invest significantly in advanced monitoring systems to ensure real-time data collection, aiding in prompt interventions, precise diagnoses and comprehensive patient care across diverse medical specialties, which helps boost segment expansion.

The blood glucose monitoring systems segment is expected to have the highest CAGR during the forecast period

The blood glucose monitoring systems segment is poised for substantial growth in the patient monitoring device market due to the increasing prevalence of diabetes globally, which has amplified the demand for efficient and user-friendly monitoring systems. Additionally, technological advancements, such as continuous glucose monitoring (CGM) and non-invasive monitoring solutions have enhanced accuracy and convenience, attracting more users. Moreover, rising healthcare awareness, coupled with government initiatives for diabetes management, propels the adoption of these monitoring systems, indicating significant growth potential for this market segment.

Region with largest share:

During the forecast period, North America's dominance in the patient monitoring device market can be attributed to several factors. The region boasts advanced healthcare infrastructure, significant healthcare expenditure, and a high adoption rate of innovative medical technologies. Moreover, favorable reimbursement policies, a large patient pool, and a proactive approach toward healthcare management contribute to the market's growth. Additionally, continuous technological advancements and robust research & development initiatives further solidify North America's position.

Region with highest CAGR:

During the forecast period, the Asia-Pacific region is set for the highest growth in the patient monitoring device market due to the region's burgeoning population, rapid urbanization, and increasing healthcare spending. Along with these rising chronic diseases, a growing geriatric population fuels the need for continuous monitoring solutions. Additionally, expanding healthcare infrastructure, government initiatives promoting healthcare access and the adoption of innovative technologies contribute to the region's significant growth.

Key players in the market:

Some of the key players in Patient Monitoring Devices Market include Abbott Laboratories, Boston Scientific Corporation, Draeger, Edwards Lifesciences Corporation, GE Healthcare, Infinium Medical, Masimo Corporation, Medtronic PLC, Mindray Medical International Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Healthcare, Philips Healthcare, Siemens Healthineers, Smiths Medical, Inc., Spacelabs Healthcare, Welch Allyn and ZOLL Medical Corporation.

Key Developments:

In October 2023, Dozee introduces ambulatory connected patient monitoring system - 'Dozee Pro Ex' Equipped with an AI-powered early warning system that tracks the trends of vital parameters and provides timely alerts for possible clinical deterioration.

In August 2023, With FDA nod, GE HealthCare paints US launch of Portrait patient monitoring system. More than a year after unveiling its wearable, wireless patient monitoring system-with CE mark already in hand, allowing it to be used across Europe-GE HealthCare is bringing the Portrait Mobile technology across the pond. The system has secured FDA 510(k) clearance, the company announced Monday, allowing it to be used in hospitals in the U.S.

In April 2023, Honeywell has developed a real-time health monitoring system, which captures and records patients' vital signs both within the hospital setting and remotely.

Products Covered:

• Blood Glucose Monitoring Systems
• Cardiac Monitoring Devices
• Multi-parameter Monitoring Devices
• Respiratory Monitoring Devices
• Temperature Monitoring Devices
• Hemodynamic/Pressure Monitoring Devices
• Neuromonitoring Devices
• Weight Monitoring Devices
• Other Products

End Users Covered:

• Ambulatory Surgery Centers
• Clinics
• Home Care Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Patient Monitoring Devices Market, By Product

• 5.1 Introduction
• 5.2 Blood Glucose Monitoring Systems
  • 5.2.1 Self-monitoring Blood Glucose Systems
  • 5.2.2 Continuous Glucose Monitoring Systems
• 5.3 Cardiac Monitoring Devices
  • 5.3.1 Electrocardiogram (ECG) Devices
  • 5.3.2 Event Monitors
  • 5.3.3 Implantable Loop Recorders
  • 5.3.4 Mobile Cardiac Telemetry Monitors
  • 5.3.5 Smart/Wearable ECG Monitors
  • 5.3.6 Other Cardiac Monitoring Devices
• 5.4 Multi-parameter Monitoring Devices
  • 5.4.1 Low-acuity Monitoring Devices
  • 5.4.2 Mid-acuity Monitoring Devices
  • 5.4.3 High-acuity Monitoring Devices
• 5.5 Respiratory Monitoring Devices
  • 5.5.1 Capnographs
  • 5.5.2 Peak Flow Meters
  • 5.5.3 Pulse Oximeters
  • 5.5.4 Spirometers
  • 5.5.5 Other Respiratory Monitoring Devices
• 5.6 Temperature Monitoring Devices
  • 5.6.1 Handheld Temperature Monitoring Devices
  • 5.6.2 Invasive Temperature Monitoring Devices
  • 5.6.3 Smart Temperature Monitoring Devices
  • 5.6.4 Table-top Temperature Monitoring Devices
  • 5.6.5 Wearable Continuous Monitoring Devices
  • 5.6.6 Other Temperature Monitoring Devices
• 5.7 Hemodynamic/Pressure Monitoring Devices
  • 5.7.1 Blood Pressure Monitors
  • 5.7.2 Cardiac Output (CO) Monitors
  • 5.7.3 Central Venous Pressure (CVP) Monitoring
  • 5.7.4 Intracranial Pressure (ICP) Monitoring
  • 5.7.5 Intravascular Volume Monitors
  • 5.7.6 Other Hemodynamic/Pressure Monitoring Devices
• 5.8 Neuromonitoring Devices
  • 5.8.1 Cerebral Oximeters
  • 5.8.2 Electroencephalography (EEG) Machines
  • 5.8.3 Electromyography (EMG) Machines
  • 5.8.4 Intracranial Pressure Monitors
  • 5.8.5 Magnetoencephalograph Machines
  • 5.8.6 Transcranial Doppler Machines
  • 5.8.7 Other Neuromonitoring Devices
• 5.9 Weight Monitoring Devices
  • 5.9.1 Digital
  • 5.9.2 Analog
• 5.10 Other Products

6 Global Patient Monitoring Devices Market, By End User

• 6.1 Introduction
• 6.2 Ambulatory Surgery Centers
• 6.3 Clinics
• 6.4 Home Care Centers
• 6.5 Hospitals
• 6.6 Other End Users

7 Global Patient Monitoring Devices Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Abbott Laboratories
• 9.2 Boston Scientific Corporation
• 9.3 Draeger
• 9.4 Edwards Lifesciences Corporation
• 9.5 GE Healthcare
• 9.6 Infinium Medical
• 9.7 Masimo Corporation
• 9.8 Medtronic PLC
• 9.9 Mindray Medical International Limited
• 9.10 Natus Medical Incorporated
• 9.11 Nihon Kohden Corporation
• 9.12 Nonin Medical, Inc.
• 9.13 Omron Healthcare
• 9.14 Philips Healthcare
• 9.15 Siemens Healthineers
• 9.16 Smiths Medical, Inc.
• 9.17 Spacelabs Healthcare
• 9.18 Welch Allyn
• 9.19 ZOLL Medical Corporation